Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Hong Kong Children's Hospital, Kowloon

National Medical Research Center Pediatric Hematology, Oncology and Immunology n.a Dmitry Rogachev, Moscow

Research Institute of Pediatric Oncology ad Hematology of N.N. Blokhin National Medical Research Center of Oncology, Moscow

Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantation Bone marrow Transplant Clinic, Saint Petersburg

ICON Cancer Centre Novena, Singapore

KK Women's and Children's Hospital, Singapore

Asan Medical Center Childrens Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Soeul